Currencies / CLRB
CLRB: Cellectar Biosciences Inc
4.97
USD
0.28
(5.97%)
CLRB exchange rate has changed by 5.97% for today. During the day, the instrument was traded at a low of 4.69 and at a high of 5.09.
Follow Cellectar Biosciences Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CLRB News
- Zacks All You Need to Know About Cellectar Biosciences (CLRB) Rating Upgrade to Buy
- Investing Cellectar Biosciences prices $6 million public offering
- Investing Cellectar Biosciences provides update on clinical programs and preclinical data
- Investing Cellectar and Nusano sign multi-year radioisotope supply agreement
- Investing Cellectar Biosciences enacts one-for-thirty reverse stock split on Nasdaq
- Investing Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer (TNBC)
- TipRanks Upcoming Stock Splits This Week (June 23 to June 27) – Stay Invested - TipRanks.com
- Benzinga Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket - Aptevo Therapeutics (NASDAQ:APVO), Arqit Quantum (NASDAQ:ARQQ)
- Investing Cellectar Biosciences announces 1:30 reverse stock split
- Investing Cellectar reports improved survival in pediatric brain tumor trial
- Benzinga Crude Oil Falls Over 1%; ISM Services PMI Tumbles In May - AnaptysBio (NASDAQ:ANAB), Asana (NYSE:ASAN)
- Investing Cellectar Biosciences stock soars on FDA breakthrough designation
- Benzinga What's Behind Cellectar Biosciences' Stock Surge? FDA Update Explained - Cellectar Biosciences (NASDAQ:CLRB)
- Benzinga US Stocks Higher; Dollar Tree Shares Plunge After Q1 Earnings - Cellectar Biosciences (NASDAQ:CLRB), Dollar Tree (NASDAQ:DLTR)
- Investing FDA grants breakthrough status to Cellectar’s cancer drug
Daily Range
4.69
5.09
Year Range
0.22
10.19
- Previous Close
- 4.71
- Open
- 4.69
- Bid
- 4.97
- Ask
- 5.27
- Low
- 4.69
- High
- 5.09
- Volume
- 75
- Daily Change
- 5.97%
- Month Change
- -5.87%
- 6 Months Change
- 1888.00%
- Year Change
- 127.98%
30 July, Wednesday
12:15
USD
- Act
- 104 K
- Fcst
- 57 K
- Prev
- -33 K
12:30
USD
- Act
- 3.0%
- Fcst
- 0.4%
- Prev
- -0.5%
12:30
USD
- Act
- 2.0%
- Fcst
- 3.6%
- Prev
- 3.8%
12:30
USD
- Act
- 2.5%
- Fcst
- 3.3%
- Prev
- 3.5%
12:30
USD
- Act
- 2.1%
- Fcst
- 3.1%
- Prev
- 3.7%
12:30
USD
- Act
- 1.4%
- Fcst
- 0.8%
- Prev
- 0.5%
12:30
USD
- Act
- 6.3%
- Fcst
- -1.5%
- Prev
- -3.1%
14:00
USD
- Act
- -0.8%
- Fcst
- 1.6%
- Prev
- 1.8%
14:00
USD
- Act
- -2.8%
- Fcst
- 9.6%
- Prev
- 1.1%
14:00
USD
- Act
- 72.0
- Fcst
- Prev
- 72.6
14:30
USD
- Act
- 7.698 M
- Fcst
- 0.914 M
- Prev
- -3.169 M
14:30
USD
- Act
- 0.690 M
- Fcst
- 0.114 M
- Prev
- 0.455 M
14:30
USD
- Act
- 1.317 M
- Fcst
- 0.738 M
- Prev
- -0.740 M
14:30
USD
- Act
- 0.130 M
- Fcst
- -0.004 M
- Prev
- 0.095 M
14:30
USD
- Act
- 3.635 M
- Fcst
- -0.111 M
- Prev
- 2.931 M
14:30
USD
- Act
- 0.676 M
- Fcst
- 0.915 M
- Prev
- 0.282 M
14:30
USD
- Act
- 0.739 M
- Fcst
- 0.608 M
- Prev
- 0.003 M
14:30
USD
- Act
- -2.724 M
- Fcst
- 0.879 M
- Prev
- -1.738 M
14:30
USD
- Act
- -0.025 M
- Fcst
- Prev
- 0.087 M
14:30
USD
- Act
- -0.1%
- Fcst
- Prev
- 1.6%
18:00
USD
- Act
- Fcst
- Prev
18:00
USD
- Act
- Fcst
- Prev
- 4.50%
18:30
USD
- Act
- Fcst
- Prev